Is the treatment of high-risk SMM the way for achieving the cure?
Multiple Myeloma Hub
00:00
Genomic Landscape Variations and Risk Assessment in Myeloma Pre-cursor Diseases
Exploring differences in genomic landscapes between stable and progressive precursors, the chapter delves into the significance of identifying patients with monoclonal gammopathy or smoldering Myeloma to gauge their risk of progression. It also covers risk models and clinical trials advocating for early treatment in high-risk Myeloma cases.
Transcript
Play full episode
